Apr 05, 2020
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
Apr 03, 2020
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
Apr 03, 2020
United States Clinical Laboratory Testing Market Insights by Types of Tests, Labs & Diseases - Forecast to 2022
Apr 03, 2020
Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
Apr 02, 2020
Dynacure Announces EUR50M ($55M) Series C Financing
Apr 02, 2020
Visiongain Launches Report Examining the Potential in the $11bn Pharma Contract Sales Market
Apr 02, 2020
Cellect Biotechnology Receives New Patent Allowance in China
Apr 02, 2020
Rgenta Therapeutics Launches with $20 Million Seed Investment
Apr 02, 2020
Stem Cell Therapy for Colon Cancer
Apr 02, 2020
Plug and Play Partners with Sanofi as Anchor Partner for Innovation Platform
Apr 02, 2020
Astellas Pharma US and Astellas Global Health Foundation COVID-19 Pandemic Response
Apr 02, 2020
Bausch Health Companies Inc. Will Hold Virtual Annual Meeting Of Shareholders On April 28
Apr 01, 2020
Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!
Apr 01, 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Apr 01, 2020
Macromoltek Announces Computational De Novo Antibody Design Offering, Targeting COVID-19
Apr 01, 2020
Locana Expands Leadership Team with Appointment of Micah Mackison, as Chief Business Officer
Apr 01, 2020
2020 COVID 19 Drug Pipeline Report- Current Status, Phase, Companies, Pre-Clinical And Clinical Drugs
Apr 01, 2020
Global Biosimilars Market (2020 to 2025) - New Indications and the Patent Expiry of Biologic Products Present Lucrative Opportunities
Apr 01, 2020
Johnson & Johnson Postpones 2020 Medical Devices Business Review Due to the Coronavirus
Mar 31, 2020
3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2%